| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/18/2013 | CN103459377A Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators |
| 12/18/2013 | CN103458919A Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 12/18/2013 | CN103450359A Antagonist antibodies against GDF-8 and uses in treatment ofals and other GDF-8-associated disorders |
| 12/18/2013 | CN103450357A Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 12/18/2013 | CN103450304A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 12/18/2013 | CN103450214A Glucopyranesyl derivative, preparation method thereof and application thereof in medicines |
| 12/18/2013 | CN103446392A Traditional Chinese medicine for curing hyperthyroidism |
| 12/18/2013 | CN103446387A Traditional Chinese medicine composition for treating hyperthyroidism and preparation method thereof |
| 12/18/2013 | CN103446299A Traditional Chinese medicine for treating thyroid cyst |
| 12/18/2013 | CN103446139A Medicine composition for treating metabolic syndrome |
| 12/18/2013 | CN102764315B Medicine for treating goiter |
| 12/18/2013 | CN102307852B Cyclic amine compounds |
| 12/12/2013 | WO2013184216A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency |
| 12/12/2013 | US20130331310 Prodrug of an Ice Inhibitor |
| 12/12/2013 | CA2875827A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency |
| 12/11/2013 | EP2670427A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 12/11/2013 | CN103443106A Novel octahydrothienoquinoline derivatives, pharmaceutical compositions comprising the derivatives and uses of the pharmaceutical compositions |
| 12/11/2013 | CN103443097A Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders |
| 12/11/2013 | CN103443094A Pyrazole derivative |
| 12/11/2013 | CN103435612A Compound for treating diabetes mellitus |
| 12/11/2013 | CN103432531A Traditional Chinese medicine for treating thyroid-associated ophthalmopathy used in stable phase |
| 12/11/2013 | CN103432476A Composition consisting of effective traditional Chinese medicine parts and used for treating hyperthyroidism |
| 12/11/2013 | CN103432339A Traditional Chinese composition and traditional Chinese preparation and application thereof |
| 12/11/2013 | CN103432338A Energy liquid matched with energy thin body meter |
| 12/11/2013 | CN103432333A Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism |
| 12/11/2013 | CN103432301A Traditional Chinese medicine effective part composition for treating primary adrenocortical insufficiency |
| 12/11/2013 | CN103432237A Composition consisting of effective traditional Chinese medicine parts and used for treating hypercortisolism |
| 12/11/2013 | CN103431387A Whitening and freckle-removing traditional Chinese medicine composition and preparation process thereof |
| 12/11/2013 | CN103430903A Method for preparing non-human animal model with opportunistic infections and chronic wasting diseases and medicament screened by using same |
| 12/11/2013 | CN102872351B Medicament for treating thyroiditis and preparation method thereof |
| 12/11/2013 | CN102716313B Anti-dairy cow transport stress pharmaceutical composition |
| 12/11/2013 | CN102652808B Menstruation regulating and beautifying capsule |
| 12/11/2013 | CN102153538B Benzocyclodirivative |
| 12/11/2013 | CN101669935B Drug combination containing prunetin and application thereof in drugs |
| 12/10/2013 | US8603977 Conformationally constrained parathyroid hormone (PTH) analogs |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | US8603464 Alkaline phosphatase to reduce weight gain or induce weight loss |
| 12/10/2013 | CA2608957C Pyrrolidine derivative or salt thereof |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/05/2013 | WO2013177607A1 Methods and compositions for improving a response to a metabolic stress |
| 12/05/2013 | US20130324759 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 12/05/2013 | CA2875348A1 Chemical suppressors of neurotoxicity in synucleinopathic diseases |
| 12/05/2013 | CA2874876A1 Methods and compositions for improving a response to a metabolic stress |
| 12/04/2013 | EP2668944A1 Aromatase activator |
| 12/04/2013 | EP2667851A1 Testosterone formulations |
| 12/04/2013 | CN103421011A Method for preparing sitagliptin phosphate anhydrous crystal form I |
| 12/04/2013 | CN103420890A 3-pyrrole carboxylic acid derivatives, and preparing method and application thereof |
| 12/04/2013 | CN103417991A Application of human miR-148a to preparation of medicine for improving adipose cell insulin sensitivity |
| 12/04/2013 | CN103417989A Application of human miR-26b to preparation of medicine for improving insulin sensitivity |
| 12/04/2013 | CN103417823A Traditional Chinese medicine for treating hyperthyroidism |
| 12/04/2013 | CN103417789A Traditional Chinese medicine for treating simple goiter |
| 12/04/2013 | CN103417499A Preparation method of somatostatin freeze-dried powder injection |
| 12/04/2013 | CN102552163B Metoprolol tartrate sustained release pellet and preparation method thereof |
| 12/04/2013 | CN102327309B Barberry bark extractive and use of barberry bark extractive and barberry bark |
| 12/03/2013 | US8598120 Methods for treatment using amylin family peptides |
| 12/03/2013 | US8598119 Methods and compositions for sleep disorders and other disorders |
| 12/03/2013 | CA2449426C Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 11/28/2013 | WO2013177505A1 Diabetes biomarkers |
| 11/27/2013 | EP2666366A1 Methods and compositions for treating feline hyperthyroidism |
| 11/27/2013 | EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
| 11/27/2013 | CN103415218A 饮料 Beverages |
| 11/27/2013 | CN103405768A Methods for the treatment of IL-1[beta] related diseases |
| 11/27/2013 | CN103405751A Composition with cell repairing function and preparation method and application thereof |
| 11/27/2013 | CN103405729A Traditional Chinese medicine for treating stationary thyroid-associated ophthalmopathy |
| 11/27/2013 | CN103405687A Application of soup for nourishing kidney and liver in preparing medicine for treating hyperprolactinemia caused by antipsychotics |
| 11/27/2013 | CN103405508A Method for extracting oestrogen active ingredients in cistanche |
| 11/27/2013 | CN103405394A Metoprolol tartrate sustained release tablet and preparation method thereof |
| 11/27/2013 | CN103405390A Preparation method of lecithin-bound iodine enteric-coated pellet tablet |
| 11/27/2013 | CN102197044B Peptide having anti-diabetic activity and use thereof |
| 11/27/2013 | CN101474239B Maackia amurensis extract as well as extracting method and use thereof |
| 11/21/2013 | WO2013173382A1 Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein |
| 11/21/2013 | WO2013171684A1 Progesterone receptor modulators for use in preventing or treating androgen mediated diseases |
| 11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
| 11/21/2013 | US20130309236 Anti-interferon-alpha antibodies |
| 11/21/2013 | US20130309215 Pharmaceutical composition |
| 11/20/2013 | EP2664325A1 Methods for preventing or treating androgen mediated diseases |
| 11/20/2013 | EP2272869B1 Angiopoietin-2 specific binding agents |
| 11/20/2013 | EP1847244B1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 11/20/2013 | CN103403017A Novel 19-nor-steroids and their use for treating progesterone-dependent conditions |
| 11/20/2013 | CN103393683A Application of SIRT2 inhibitor in pharmacy |
| 11/20/2013 | CN102526127B Flash type extraction method for active constituents in cordyceps militaris |
| 11/20/2013 | CN101896178B Heterocyclic compounds as CRTH2 receptor antagonists |
| 11/19/2013 | US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease |
| 11/19/2013 | CA2512188C Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 11/14/2013 | WO2013168455A1 Synergistic antidiabetic therapeutic agent |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130303501 Pharmaceutical composition and method for treating hypogonadism |
| 11/14/2013 | US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors |
| 11/13/2013 | CN103391945A Isoxazolidine derivatives |
| 11/13/2013 | CN103386131A Pharmaceutical composition containing adenosine or derivative of adenosine |
| 11/13/2013 | CN103386008A Chinese medicine composition for treating endocrine dyscrasia |
| 11/13/2013 | CN103385913A Radix Astragali extract and its preparation method and preparation |
| 11/13/2013 | CN102336763B Synthesis method for pyranocoumarin derivatives |
| 11/12/2013 | US8580563 Placental stem cells |
| 11/12/2013 | CA2606683C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 11/12/2013 | CA2596884C Nandrolone 17.beta.-carbonates |
| 11/12/2013 | CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 11/12/2013 | CA2448022C Compositions for protein delivery via the pulmonary route |
| 11/07/2013 | US20130295009 Method of treating inflammation |